Hermetica Superfood Encyclopedia
The Short Answer
Coleus scutellarioides leaves contain flavonoids, phenolic acids (including rosmarinic acid, caffeic acid, and gallic acid), anthocyanins, and volatile sesquiterpenes such as spathulenol (24.57%) and germacrene-D (14.53%), which collectively exhibit free-radical scavenging activity in vitro. In vitro antioxidant assays using DPPH and related methods have demonstrated IC50 values in the range of 70–244 µg/mL for crude and concentrated leaf extracts, though no clinical trials in humans have been conducted to confirm therapeutic efficacy for wound healing or any other indication.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordColeus scutellarioides benefits
Inu — botanical close-up
Health Benefits
**Antioxidant Activity**
Leaf extracts exhibit measurable free-radical scavenging capacity in DPPH assays (IC50 approximately 70–244 µg/mL), attributed primarily to polyphenols including quercetin, rosmarinic acid, caffeic acid, and gallic acid; this activity is enhanced in concentrated extracts (1.64 mg QE/g flavonoids) versus crude dried material (0.59 mg QE/g).
**Traditional Wound and Sore Management**
In Samoan ethnomedicine, fresh or prepared leaves of inu are applied topically to skin sores and lesions; this use is consistent with the plant's documented phenolic and flavonoid content, which may contribute antimicrobial and anti-inflammatory properties, though no controlled clinical studies have validated this application.
**Potential Anti-inflammatory Effects**
Phenolic constituents such as rosmarinic acid and caffeic acid are recognized inhibitors of pro-inflammatory mediators in related plant systems; while no direct mechanistic studies on C. scutellarioides in inflammatory models have been published, the phytochemical profile suggests plausible anti-inflammatory activity at the site of topical application.
**Antimicrobial Potential**
Tannins and saponins identified in leaf extracts possess well-documented membrane-disrupting and protein-precipitating properties relevant to inhibition of bacterial growth; alkaloid fractions may further contribute to antimicrobial effects, though species-specific MIC data for C. scutellarioides are not yet established in peer-reviewed literature.
**Volatile Compound Richness**
In vitro and in vivo profiling reveals a complex volatile fraction totaling up to 10,579.11 µg/g in hormone-supplemented cultures, dominated by spathulenol, germacrene-D, and bicyclogermacrene, compounds that in other plant systems have demonstrated antifungal and anti-inflammatory bioactivity, suggesting aromatic preparations (e.g., poultices) may contribute biological effects beyond simple phenolic delivery.
**Phytochemical Diversity Supporting Skin Health**
The combination of anthocyanins, flavonoids, and phenolic acids in C. scutellarioides leaves provides a broad-spectrum phytochemical matrix that, by analogy with better-studied species containing these compounds, may support tissue-protective and antioxidant activity in skin applications consistent with traditional use.
Origin & History
Natural habitat
Coleus scutellarioides is native to tropical and subtropical Asia, including the Philippines, Indonesia, and surrounding Pacific Island regions, and has naturalized throughout Oceania including Samoa, where it is traditionally known as 'inu.' It thrives in humid, warm climates with well-drained soils and is widely cultivated as an ornamental plant for its vibrantly pigmented, variegated foliage. In Samoan traditional practice, the plant grows in village gardens and along forest margins, where its leaves are harvested for topical medicinal applications.
“Coleus scutellarioides has a long history of ornamental cultivation across Southeast Asia and the Pacific, prized for its extraordinarily diverse leaf coloration ranging from deep purples and reds to greens and yellows, leading to its widespread use in traditional gardens throughout Melanesia, Polynesia, and Micronesia. In Samoa, the plant is known as 'inu' and holds a place in traditional healing practice, with leaves applied topically to skin sores, a use consistent with broader Pacific Island traditions of using locally available foliage for wound care in the absence of Western pharmacopeia. Related Coleus species—particularly Coleus forskohlii (now Plectranthus barbatus)—have deeper pharmacological documentation in Ayurvedic medicine, where they are used to support cardiovascular and metabolic function, suggesting the broader genus has cross-cultural medicinal relevance. The use of C. scutellarioides specifically for wound and sore treatment in Samoa has not been captured in systematic ethnobotanical surveys available in the peer-reviewed literature, representing a gap in the documentation of Pacific Island traditional medicine.”Traditional Medicine
Scientific Research
The available body of research on C. scutellarioides is restricted entirely to in vitro phytochemical characterization and bioassay studies; no randomized controlled trials, observational clinical studies, or animal model investigations of therapeutic endpoints have been published as of the available literature. Phytochemical studies have quantified total phenolic content at approximately 1.993 ± 0.005 mg/g and total flavonoid content at 191.682 ± 2.273 mg/g in leaf material, and volatile profiling has identified over a dozen compounds with pharmacognostic relevance. Antioxidant capacity has been assessed using DPPH, ABTS, and related assays across multiple extract types (aqueous and ethanolic), yielding IC50 values in the range of 70–244 µg/mL, which represent modest to moderate in vitro antioxidant potency. The overall evidence base is preclinical and fragmentary, with no standardized extract, no dose-response data in biological systems, and no validated safety or efficacy profile in humans.
Preparation & Dosage
Traditional preparation
**Traditional Topical Preparation (Samoan)**
Fresh leaves are applied directly to skin sores or may be crushed into a poultice; no standardized preparation protocol, duration of application, or frequency is documented in ethnobotanical literature.
**Aqueous Extract (Research Use Only)**
Water extracts have been prepared by decoction or cold maceration and concentrated via rotary evaporator or freeze-drying for in vitro antioxidant testing; concentrations used in assays range from 70 to 244 µg/mL (IC50 range), but these figures reflect laboratory conditions, not therapeutic doses.
**Ethanolic Extract (Research Use Only)**
Ethanol extracts have been used in phytochemical screening and bioassay studies; no clinically applicable dose has been derived.
**Standardization**
No commercial supplement is standardized for C. scutellarioides; no standardization percentage for quercetin, rosmarinic acid, or any other marker compound has been established.
**Effective Dose**
No effective dose for any human health outcome has been established; dosage guidance cannot be responsibly provided in the absence of clinical data.
Nutritional Profile
C. scutellarioides leaves are not consumed as a significant dietary food source and have not been evaluated for macronutrient content (protein, carbohydrate, fat, fiber) in nutritional studies. Key phytochemicals identified include total flavonoids at 0.59–1.64 mg quercetin equivalents (QE)/g depending on extract concentration, total phenolics at approximately 1.993 mg/g, and individual compounds including quercetin, rosmarinic acid, caffeic acid, and gallic acid at unquantified individual concentrations. The volatile fraction contributes spathulenol (24.57% of volatile fraction), germacrene-D (14.53%), bicyclogermacrene (11.24%), nonacosan (9.74%), and morillol (4.85%), with total volatiles ranging from 2,848.59 µg/g in field-grown plants to 10,579.11 µg/g in tissue-culture conditions. Anthocyanins responsible for leaf pigmentation are present but have not been quantified in isolation. Bioavailability of polyphenolic constituents via topical application—the primary traditional route—has not been assessed.
How It Works
Mechanism of Action
The antioxidant activity of C. scutellarioides leaf extracts is primarily attributed to hydrogen atom transfer and single electron transfer mechanisms mediated by polyphenolic compounds—particularly quercetin, rosmarinic acid, caffeic acid, and gallic acid—which donate electrons or hydrogen atoms to neutralize reactive oxygen species (ROS) such as the DPPH radical in vitro. Anthocyanins present in the vivid leaf pigmentation may additionally stabilize oxidative intermediates through resonance delocalization of unpaired electrons across their aromatic ring systems. Tannins and saponins may disrupt microbial cell membrane integrity through nonspecific binding to membrane proteins and lipid bilayer destabilization, which could partly account for traditional topical efficacy against infected sores. No molecular target interactions (e.g., specific enzyme inhibition, receptor binding, or gene expression modulation) for C. scutellarioides constituents have been characterized in published studies, and mechanistic data remain extrapolated from related plant species or compound classes.
Clinical Evidence
No clinical trials of any design have evaluated C. scutellarioides (inu) for any health outcome in human populations. All available efficacy data derive from in vitro assays measuring antioxidant capacity and phytochemical content of crude or concentrated leaf extracts. There are no reported effect sizes, no patient populations studied, no primary endpoints measured in living organisms beyond cell-free radical scavenging assays, and consequently no basis for clinical confidence in any therapeutic claim. The sole context for human use is Samoan ethnomedicinal tradition, which describes topical application of leaves to sores, a practice that has not been subject to any form of controlled investigation.
Safety & Interactions
No formal clinical safety assessment, toxicology study, or pharmacovigilance data for C. scutellarioides has been published, and human tolerability is entirely uncharacterized; the absence of evidence of harm should not be interpreted as evidence of safety. Physical standardization parameters for dried leaf material (loss on drying 8.86% w/w, total ash 9.35% w/w, acid-insoluble ash within acceptable pharmacopoeial limits) confirm basic raw material quality standards but provide no information on toxicological risk in humans. No drug interactions have been studied or reported; however, the presence of tannins (which can chelate minerals and bind to drug molecules) and flavonoids (which may modulate cytochrome P450 enzymes in other plant species) theoretically warrants caution in individuals taking medications with narrow therapeutic windows. Pregnancy, lactation, pediatric use, and contraindications are entirely unassessed; topical use should be approached conservatively until safety data become available, and internal consumption cannot be recommended.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Coleus scutellarioidesInuPainted nettleCommon coleusPlectranthus scutellarioidesSolenostemon scutellarioides
Frequently Asked Questions
What is inu used for in Samoan traditional medicine?
In Samoan traditional medicine, inu (Coleus scutellarioides) leaves are applied topically to skin sores and lesions as a wound treatment. This practice is consistent with the plant's documented content of flavonoids, phenolic acids, and tannins, which possess antioxidant and potential antimicrobial properties in laboratory settings, though no clinical trials have confirmed the efficacy of this traditional application.
What are the main bioactive compounds in Coleus scutellarioides?
The leaves of Coleus scutellarioides contain a broad range of bioactive phytochemicals including flavonoids (0.59–1.64 mg QE/g), phenolic acids such as rosmarinic acid, caffeic acid, and gallic acid, anthocyanins responsible for leaf pigmentation, tannins, saponins, and alkaloids. The volatile fraction is dominated by sesquiterpenes including spathulenol (24.57%), germacrene-D (14.53%), and bicyclogermacrene (11.24%), totaling up to 10,579.11 µg/g in some culture conditions.
Is there clinical trial evidence supporting Coleus scutellarioides as a supplement?
No clinical trials of any design have been conducted on Coleus scutellarioides in human subjects, and no animal model studies of therapeutic endpoints have been published. All available evidence consists of in vitro phytochemical analyses and free-radical scavenging assays, giving this plant an evidence score consistent with preliminary preclinical research only; it cannot currently be recommended as a supplement based on clinical evidence.
Is Coleus scutellarioides (inu) safe to use?
The safety of Coleus scutellarioides has not been formally evaluated in humans; no toxicology studies, adverse event reports, or drug interaction data are available in peer-reviewed literature. Basic quality parameters for dried leaf material (total ash 9.35% w/w, loss on drying 8.86% w/w) fall within standard herbal material limits, but these do not constitute a safety assessment. Caution is advised, particularly for internal use, and pregnancy or lactation should be considered contraindications in the absence of safety data.
How does Coleus scutellarioides differ from Coleus forskohlii?
Coleus forskohlii (now classified as Plectranthus barbatus) is a distinct species best known for its root-derived diterpene forskolin, which activates adenylyl cyclase and elevates cellular cAMP, a well-characterized mechanism with clinical data supporting cardiovascular and metabolic applications. Coleus scutellarioides is primarily an ornamental foliage plant studied for leaf polyphenols and antioxidant activity, lacks forskolin, and has no established clinical applications; the two plants are related within the Lamiaceae family but have substantially different phytochemical profiles and evidence bases.
What forms of Coleus scutellarioides (inu) are available, and which form has the highest antioxidant potency?
Coleus scutellarioides is available as dried leaf material, crude powder, and concentrated extracts. Concentrated leaf extracts deliver significantly higher antioxidant activity (1.64 mg quercetin equivalents per gram of flavonoids) compared to crude dried material (0.59 mg QE/g), making standardized extracts more potent for free-radical scavenging benefits.
Does Coleus scutellarioides interact with common medications or blood thinners?
While Coleus scutellarioides contains polyphenolic compounds with bioactive potential, specific drug interaction studies with common medications are limited. Individuals taking anticoagulants, antiplatelet drugs, or blood pressure medications should consult a healthcare provider before use, as polyphenol-rich herbs may potentiate certain drug effects.
What are the key bioactive polyphenols in inu (Coleus scutellarioides) and how do they contribute to its health effects?
Inu leaf extracts contain quercetin, rosmarinic acid, caffeic acid, and gallic acid—polyphenols responsible for measurable antioxidant activity in laboratory assays (DPPH IC50: 70–244 µg/mL). These compounds work synergistically to scavenge free radicals, supporting the traditional use of inu for wound healing and skin health, though human clinical confirmation remains limited.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w inu-coleus-scutellarioides curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
